Press Releases

SMi Reports: Exploring the challenges, practices and drivers in the aftermath of the transition for Parallel Trade Join us at SMi’s 15th annual Parallel Trade Conference bringing…
Read More...

SMi Group Reports: The 4th Annual Pharmaceutical Microbiology West Coast Conference will convene virtually on June 17th – 18th 2021 with two pre-conference interactive workshops on June…
Read More...

SMi Group Reports: In the lead up to the 5th Annual Highly Potent Active Pharmaceutical Ingredients Virtual Conference, taking place on 10th-11th May 2021, Justin Mason-Home, HPAPI…
Read More...

SMi Reports: There will be a workshop on ‘Developing Apps for Connected Drug Delivery Devices- a practical and integrated HF approach SMi is proud to present the Injectable Drug…
Read More...

Harnessing the activation of innate immunity has become the forefront of new cancer immunotherapies. Only this month SQZ Biotech received FDA clearance for an IND on a cell therapy…
Read More...

In just the last week few weeks there have been clinical updates from Pfizer, Sarepta and Audentes on their programs in muscular disorders. The timely Gene Therapy for Muscular…
Read More...

SMi Reports: SMi Group is proud to introduce some insightful content from our chair and expert speaker of the Pre-filled Syringes East Coast virtual conference 2021 The upcoming…
Read More...

SMi Reports: Bringing together industry experts to discuss the challenges and drivers of the industry This conference is a must-attend show for anyone involved in the parallel trade…
Read More...

SMi Reports: Two exclusive interviews with Lacey Batts at Novo Nordisk and Joanny Salvas at Pfizer, who will be speaking at the 4th Annual Pharmaceutical Microbiology East Coast…
Read More...

SMi reports: Registration is now open for the Pre-Filled Syringes West Coast, which returns as a virtual conference on 15th-16th June 2021. The highly anticipated event will explore…
Read More...

SMi Reports: The 5th Annual Highly Potent Active Pharmaceutical Ingredients Conference (HPAPi) will take place for its 5th consecutive year as a virtual conference to explore…
Read More...

SMi Reports: Three AI in drug discovery start-ups to join the conference GlamourousAI, Cloud Pharmaceuticals and Envisagenics , who will be speaking at the 2nd Annual AI in Drug…
Read More...

Chronic and rare kidney disease drug development has been heating up as stakeholders bustle to deliver benefits beyond SGLT2s.  Already in January 2021, Bayer and AstraZeneca have been…
Read More...

Following the FDA’s approval of 12 personalised medicines and 7 diagnostics in 2019, then a record number of precision oncology drugs in H1 2020, demand is high for Dx-enabled therapies…
Read More...

With the global oligonucleotide therapeutics market forecasted to climb to a record value of 7 billion dollars in the next 3 years, a rapidly increasing volume of FDA approvals and…
Read More...

AI Driven Drug Repositioning and Repurposing Summit taking place April 20-21, is an exciting online event which shines a light on the benefits of AI tools in drug repurposing and helps…
Read More...

Join our ground-breaking new conference dedicated to drive forward the development of effective therapies for chronic fibrosing ILDs. The ILD Summit takes place this April 27-29,…
Read More...

SMi Reports: Hear key Sessions from Amgen, BSI, FDA, Biogen, Takeda, Janssen, Merck, Alexion Pharmaceuticals, Regeneron Pharmaceuticals and many more! The two-day conference agenda…
Read More...

The fully launched MAH and priority review pathways from the NMPA (National Medical Products Administration) is stimulating new demand in China for 2021. The recently hosted CPhI…
Read More...

SMi Reports: The only B2B parallel trade conference in Europe This conference will bring together industry experts to discuss the challenges and drivers of the industry, including…
Read More...